JPRN-UMIN000016951已完成2 期
The multicenter continuous clinical trial of the safety and efficacy of bezafibrate for mitochondrial fatty acid beta-oxidation disorders - BezFAOD continuous study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient who; (1) is considered ineligible for enrolling the study by a principal investigator or sub-investigator
研究者
相似试验
已完成
2 期
The multicenter continuous clinical study on the safety of long-term administration of bezafibrate for mitochondrial fatty acid beta-oxidation disordersmitochondrial fatty acid beta-oxidation disordersJPRN-UMIN000017984Shimane University Hospital10
已完成
不适用
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Cancer - BreastBreast CancerACTRN12623000205639OncoRes Medical Pty Ltd30
进行中（未招募）
1 期
Alendronate for Prevention of antiretroviral therapy-associated bone loss.Human immunodeficiency virus (HIV) infectionMedDRA version: 17.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-004819-37-IEniversity College Dublin80
进行中（未招募）
1 期
Alendronate for Prevention of antiretroviral therapy-associated bone loss.Human immunodeficiency virus (HIV) infectionMedDRA version: 20.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-004819-37-DKniversity College Dublin80
进行中（未招募）
1 期
Alendronate for Prevention of antiretroviral therapy-associated bone loss.EUCTR2014-004819-37-GBniversity College Dublin80